Table of Contents
Overview
Definition and Scope
Medicinal chemistry is a multidisciplinary field that integrates organic chemistry, biochemistry, pharmacology, and other scientific disciplines to study the design, synthesis, and actions of pharmaceutical drugs. Its primary objective is to design, chemically synthesize, and develop new drug formulations, which involves the combination of synthetic organic chemistry with various biological specialties.[3.1] The scope of medicinal chemistry encompasses the discovery and development of new therapeutic agents, particularly focusing on small organic molecules. This practice involves not only synthetic organic chemistry but also aspects of natural products and computational chemistry, which are closely linked with chemical biology, enzymology, and structural biology.[4.1] Medicinal chemistry operates at the intersection of multiple scientific domains, including biochemistry, molecular biology, pharmacognosy, pharmacology, and toxicology, thereby ensuring that the chemical agents developed are safe and effective for treating diseases.[4.1] In addition to its scientific foundations, medicinal chemistry is characterized by a blend of creativity and data-driven approaches, requiring practitioners to collaborate effectively with other scientists throughout the drug discovery process. This field demands adaptability and resilience, as drug discovery is often fraught with complexities and unexpected challenges.[6.1] Furthermore, educational pathways in medicinal chemistry vary, typically requiring a bachelor's degree, with advanced roles necessitating a master's or PhD, where students learn about biochemical processes underlying diseases and the interactions of drugs with biological systems.[6.1]Importance in Drug Development
Medicinal chemistry is pivotal in drug development, focusing on the design and synthesis of new therapeutic agents. This discipline integrates pharmacokinetics and pharmacodynamics to tailor drug properties, ensuring optimal therapeutic efficacy and safety. By understanding enzyme and receptor interactions, medicinal chemists can influence drug absorption, distribution, metabolism, and excretion, which are crucial for effective drug design [15.1]. The field emphasizes the importance of personalized medicine, where drug dosages are adjusted to individual patient needs, minimizing adverse effects and enhancing therapeutic outcomes [9.1]. Recent innovations in drug delivery systems, such as nanocarriers and bioconjugates, have further advanced medicinal chemistry by improving drug targeting and reducing side effects [12.1]. These developments underscore the role of medicinal chemistry in creating sustainable healthcare solutions by optimizing drug combinations to achieve desired therapeutic effects with minimal adverse reactions [8.1]. The integration of these principles into drug development processes is essential for establishing effective therapies that meet clinical demands [19.1]. Quantitative methods are employed to systematically balance treatment benefits against potential risks, ensuring that therapeutic strategies are both effective and safe [10.1].History
Ancient Practices and Early Discoveries
The roots of medicinal chemistry can be traced back to ancient civilizations, where herbal remedies and natural substances were commonly employed to treat various ailments. Cultures such as those in Egypt, Mesopotamia, China, and India utilized plants like aloe vera, garlic, and opium poppy for their medicinal properties, laying the groundwork for future pharmacological developments.[58.1] In addition to these herbal practices, significant figures emerged in ancient history who contributed to the understanding of medicine. The Greek god of medicine, Asclepius, symbolizes the early integration of spirituality and healing, while Hippocrates, often referred to as the "Father of Medicine," established principles that continue to influence medical ethics today through the Hippocratic Oath.[59.1] The Renaissance marked a pivotal shift in medicinal chemistry, characterized by a renewed interest in scientific inquiry and exploration. During this period, Paracelsus, a Swiss physician, played a crucial role by challenging the mystical aspects of alchemy and advocating for the use of chemical substances in medicine. His emphasis on empirical observation and experimentation laid the foundation for modern pharmacology.[60.1]Evolution of Medicinal Chemistry
Medicinal chemistry has evolved significantly over the centuries, beginning with the use of traditional herbal remedies in ancient civilizations. These early medicinal substances laid the groundwork for modern pharmaceutical practices, as plant-based compounds continue to account for more than half of all contemporary clinical drugs.[48.1] The transition from herbal medicine to modern medicinal chemistry was marked by the advent of synthetic organic chemistry, which revolutionized drug discovery by allowing for the precise synthesis of compounds with specific chemical structures.[2.1] The integration of various scientific disciplines, including biochemistry, pharmacology, and chemical biology, has further advanced the field. Medicinal chemistry now encompasses a multidisciplinary approach that combines synthetic organic chemistry with aspects of natural products and computational chemistry, aiming to discover and develop new therapeutic agents.[4.1] This interdisciplinary nature is essential for the systematic exploration of herbal remedies, as modern scientific methods provide insights into the active compounds and mechanisms of action of traditional formulations.[50.1] The evolution of medicinal chemistry has been marked by significant milestones that have transformed the field from ancient herbal remedies to modern molecular design. One of the pivotal advancements was the advent of synthetic organic chemistry, which revolutionized drug discovery by enabling the synthesis of compounds with precise chemical structures.[2.1] Additionally, the integration of biotechnology and genomics into drug discovery has ushered in the era of personalized medicine, allowing for treatments tailored to individual patient needs.[2.1] Furthermore, computational drug design has emerged as a revolutionary approach, utilizing algorithms and simulations to efficiently identify promising drug candidates. This method not only reduces costs but also accelerates development compared to traditional experimental techniques, making it indispensable in contemporary pharmaceutical research.[56.1] As advancements in computational power and molecular modeling continue to improve, they play a crucial role in the ongoing transformation of medicinal chemistry into life-saving treatments for patients worldwide.[56.1]Recent Advancements
Modern Techniques in Drug Development
Recent advancements in medicinal chemistry have significantly transformed modern techniques in drug development, particularly through the integration of interdisciplinary approaches and innovative technologies. The field has evolved to combine principles from chemistry, biology, pharmacology, and computational sciences, enabling the design and synthesis of novel therapeutic agents that address unmet medical needs.[86.1] One of the most notable advancements is the application of personalized medicine, which leverages genetic and molecular data to tailor treatments to individual patients. This approach enhances precision in diagnosis and treatment strategies, allowing for optimized therapeutic efficacy and minimized adverse effects.[91.1] The intersection of personalized medicine and network pharmacology has led to new strategies for developing therapies that are informed by comprehensive patient data, thereby promising safer and more effective treatments.[88.1] Recent advancements in our understanding of biomolecular structures have significantly influenced the development of targeted therapies in medicinal chemistry. The Protein Data Bank, which contains over 180,000 biomolecular structures as of May 2021, illustrates the importance of structural information in structure-based drug design, where small molecule ligands are designed by docking them into the binding pocket of target proteins.[97.1] This approach requires a three-dimensional structure of the reference protein, which is essential for enhancing the specificity of drug design.[97.1] Additionally, new chemical modalities, including RNA therapeutics, protein degraders, cyclopeptides, antibody-drug conjugates, and gene therapy, have matured and demonstrated clinical success, making them integral to early target appraisal in drug development.[94.1] The progress toward these innovative chemical modalities has been gradual but steady, with many of these approaches having been in development for several decades and now validating their efficacy by reaching clinical development and regulatory approval.[94.1] Recent advancements in medicinal chemistry, drug delivery technologies, and computational modeling have significantly expanded the toolbox available to overcome challenges related to bioavailability. Strategies now encompass molecular design modifications, prodrug approaches, and innovative formulation techniques such as nanocarriers and amorphous solid dispersions.[92.1] Interdisciplinary collaboration among specialists in medicinal chemistry, structural biology, preclinical safety, and translational medicine is crucial, as it leverages advancements in each field to compensate for the limitations of others.[96.1] This collaborative approach enables the refinement of lead compounds, enhancing their potency, selectivity, and safety.[95.1] Furthermore, the emergence of novel ideas, such as the use of nanorobots, has introduced powerful therapeutic tools aimed at developing highly efficacious precision medicines that can localize drugs at target sites.[93.1]Role of Computational Chemistry
The integration of computational methods has become a cornerstone in drug discovery and development efforts within the rapidly evolving landscape of pharmaceutical research. Computer-aided drug design (CADD) offers a more efficient and cost-effective approach, complementing traditional experimental techniques.[104.1] Key computational methods, including molecular docking, molecular dynamics simulations, quantum mechanics, and machine learning, play a crucial role in predicting and analyzing molecular interactions.[103.1] These tools have revolutionized modern drug discovery by providing powerful techniques to enhance the accuracy of drug design processes.[103.1] Molecular docking, in particular, serves as a pivotal computational technique that predicts the preferred orientation of small molecules (ligands) when bound to target proteins (receptors). This method has facilitated the discovery of novel antifungal agents by accurately predicting their binding modes with fungal enzymes.[105.1] Additionally, advancements in artificial intelligence (AI) and machine learning (ML) have further revolutionized drug design by accelerating virtual screening processes, predicting molecular interactions, and optimizing lead compounds.[105.1] The emergence of AI and ML in drug discovery has been driven by significant advances in computer science and the availability of large datasets, which have enhanced the capabilities of these computational tools.[127.1] Moreover, the application of molecular dynamics simulations has provided mechanistic insights into drug resistance mechanisms and ligand binding dynamics, which are crucial for the development of effective therapeutics.[105.1] As computational methods continue to evolve, they are expected to play an increasingly vital role in medicinal chemistry, particularly in optimizing high-throughput workflows and addressing complex conditions such as inflammatory bowel disease.[126.1] Overall, the advancements in computational chemistry not only streamline the drug discovery process but also pave the way for innovative therapeutic solutions.Key Concepts
Drug Design and Discovery
Drug design and discovery is a critical aspect of medicinal chemistry, encompassing various methodologies and principles aimed at developing effective therapeutic agents. The process begins with understanding the molecular structures that influence biological activity, which is essential for both structure-based drug design (SBDD) and ligand-based drug design (LBDD) approaches. SBDD utilizes the three-dimensional (3D) structure of biological targets to dock potential drug molecules, while LBDD focuses on known ligands that bind to targets to derive pharmacophore models or quantitative structure-activity relationships (QSAR).[139.1] Iterative cycles of design, synthesis, and testing are employed to refine compounds and optimize their pharmacological properties. SBDD has been particularly instrumental in the development of successful drugs, as it allows for precise targeting based on the structural characteristics of proteins.[135.1] Conversely, LBDD is advantageous when the 3D structure of the target is unknown, enabling researchers to leverage existing data on ligands to design improved compounds.[138.1] Advanced computational techniques, such as molecular docking and QSAR modeling, play a significant role in the drug discovery process. QSAR models predict the biological activities of chemical compounds based on their structural features, enhancing the screening process for potential drug candidates.[140.1] For instance, after developing a QSAR model for anticancer compounds, researchers can dock these compounds against specific targets to assess binding affinity and selectivity.[141.1] This combination of molecular docking and QSAR modeling has been successfully applied in optimizing lead compounds, such as adenosine A2A receptor antagonists for Parkinson's disease, demonstrating the efficacy of these methodologies in drug development.[142.1] In the early stages of drug development, conducting clinical research properly is essential for setting the stage for designing and conducting optimal "confirming" registrational Phase IIB/III studies for promising drug candidates.[143.1] A mechanistic approach to drug development heavily relies on pharmacokinetics (PK) and pharmacodynamics (PD) modeling and simulation, which are crucial components of this process.[143.1] These principles inform the design and optimization of drug candidates, ensuring that they effectively interact with their targets and exhibit favorable therapeutic profiles.[143.1]In this section:
Applications
Therapeutic Areas
Medicinal chemistry encompasses a wide array of applications, including the development of novel small molecule drugs and biologics, as well as innovative techniques in target identification and lead optimization.[170.1] In 2023, the FDA has approved 51 novel drugs that address a diverse range of medical conditions, including Alzheimer's disease and cancer, as well as migraines, menopausal symptoms, and post-partum depression.[188.1] This highlights the significant impact of advancements in medicinal chemistry on the development of new pharmacological therapies, ultimately enhancing patient care through the introduction of effective treatment options. Recent advancements in drug design methodologies, such as structure-based drug design (SBDD) and ligand-based drug design (LBDD), have refined the process of optimizing molecular interactions to enhance biological activity.[172.1] These techniques, combined with computational approaches like molecular docking and quantitative structure-activity relationship (QSAR) modeling, facilitate the prediction of how structural modifications can influence drug efficacy.[172.1] Furthermore, the integration of sophisticated analytical techniques ensures the purity and structural integrity of therapeutic compounds, which is vital for their safe application in clinical settings.[172.1] In 2023, the FDA approved 51 novel drugs aimed at managing a wide range of medical conditions, including Alzheimer's disease, cancer, migraines, menopausal symptoms, and postpartum depression.[188.1] Among these approvals, first-in-class (FIC) drugs have played a crucial role in new drug discovery, with 81 FIC drugs approved globally in 2023 and 2024. These drugs are characterized by their novel targets and mechanisms, which are essential for driving innovation in treatment options.[189.1] In the context of complex diseases such as inflammatory bowel disease (IBD), there is a growing interest in advanced targeted therapies that may enhance therapeutic efficacy. However, research comparing the efficacy and safety of dual biologic therapy with biologic small-molecule therapy for refractory IBD remains limited.[197.1] Additionally, therapies that combine small molecules with macromolecular biologics have been developed for treating complex infectious diseases, exemplified by the new biologic co-formulation HyQvia, which is a once-monthly treatment for adult patients.[198.1] Moreover, the rise of Click Chemistry (CC) has revolutionized drug discovery by enabling the rapid and sustainable development of complex molecules with minimal off-target effects.[174.1] This innovative approach exemplifies the adaptability and creativity required in medicinal chemistry, as researchers continuously seek to overcome challenges in drug development and optimize therapeutic outcomes.[173.1]Natural Products in Medicinal Chemistry
Natural products have played a significant role in the field of medicinal chemistry, particularly in the development of small molecule drugs. These compounds are characterized by their small size, typically ranging from 0.1 to 1 kDa, which enhances their gastrointestinal absorption into the bloodstream, making them suitable for oral administration.[200.1] The composition of these natural products often includes hydrophobic and crystalline structures, allowing them to effectively bypass lipid-rich cell membranes and exert their therapeutic effects.[200.1] In addition to their size and structure, the drug-like properties of small molecule compounds are defined by various physicochemical characteristics. These include solubility, permeability, stability, molecular weight, lipophilicity, pKa, polar surface area, shape, and reactivity.[201.1] Furthermore, the biochemical attributes of these compounds, such as metabolism, drug-drug interactions, and cellular uptake, are crucial for their efficacy and safety.[201.1] The integration of these features is essential when designing small molecule drugs that target specific biological pathways, thereby enhancing their therapeutic potential in medicinal chemistry.In this section:
Challenges And Future Directions
Current Challenges in Drug Development
One of the primary challenges in drug development is the optimization of drug-like properties, which include potency, selectivity, solubility, and metabolic stability. These properties are crucial for the successful application of synthetic medicinal chemistry in creating effective therapeutic agents.[207.1] The process of medicinal chemistry has become increasingly time-consuming, with new discovery technologies adding to the complexity of lead optimization and refinement.[209.1] Furthermore, the number of approved drugs has been declining in recent years, highlighting the need for more effective methods to discover a higher number of successful compound candidates.[208.1] In addition to these challenges, medicinal chemistry must also integrate knowledge from various scientific disciplines to address the complexities of drug discovery. This integration is essential not only for finding new drugs but also for meeting the challenges posed by the Sustainable Development Goals (SDGs).[211.1] The environmental impact of pharmaceuticals is another pressing concern, as the healthcare sector contributes significantly to global greenhouse gas emissions and can adversely affect aquatic ecosystems and drinking water resources.[236.1] The pharmaceutical industry is increasingly aware of these environmental challenges and is exploring strategies to improve sustainability in production and reduce the environmental exposure associated with drug consumption.[235.1] Moreover, the balance between potency, selectivity, and solubility remains a critical focus in drug design. For instance, charge optimization techniques have been employed to enhance both potency and selectivity in drug candidates.[248.1] However, low solubility can lead to significant issues during clinical trials, including precipitation and crystalluria, which may result in the discontinuation of poorly soluble drugs.[250.1] To mitigate these risks, strategies such as the prodrug approach have been developed to improve solubility and ensure safer clinical outcomes.[250.1]Emerging Trends and Innovations
Emerging trends in medicinal chemistry are increasingly focused on sustainability and the integration of innovative technologies to enhance drug discovery and development processes. The pharmaceutical industry is progressively adopting green chemistry principles to address environmental challenges and promote sustainability in drug development. This shift emphasizes advancements in green synthesis, sustainable drug discovery, and eco-friendly technologies, aiming to minimize environmental impact while maintaining drug efficacy.[214.1] Moreover, the incorporation of Sustainable Development Goals (SDGs) into medicinal chemistry practices is gaining traction. This approach encourages researchers to bridge the gap between sustainable practices and the medicinal chemistry community, fostering the integration of SDGs into current research and innovation. By applying SDG-specific challenges to medicinal chemistry, new methodologies for sustainable drug design and production are being promoted.[217.1] In addition to sustainability, the field is witnessing a surge in the application of artificial intelligence (AI) and machine learning (ML) in drug discovery. These technologies are revolutionizing the identification of novel therapeutics and enhancing various stages of the drug discovery process, from early target identification to lead optimization. Recent advancements in deep learning have significantly impacted the efficiency and effectiveness of these processes.[220.1] Furthermore, new chemical modalities, such as RNA therapeutics, protein degraders, and antibody-drug conjugates, are emerging as promising avenues in medicinal chemistry. These modalities have shown clinical success and are being prioritized in target appraisal, reflecting a shift towards innovative therapeutic strategies.[219.1] The integration of One Health principles into the research and development pipeline is also noteworthy. This perspective advocates for the development of environmentally friendly antiparasitic drugs, urging scientists to incorporate green chemistry methodologies into routine drug development practices, thereby promoting a more sustainable pharmaceutical pipeline.[216.1]In this section:
Sustainable Development GoalsGreenhouse Gas EmissionsAffectAquatic EcosystemsWater Resources
References
[2] History and Development of Medicinal Chemistry — Medicinal Chemistry – I Medicinal Chemistry II April 20, 2024April 20, 2024 DeepakRajputHome, Unit 1History and Development of Medicinal Chemistry From ancient herbal remedies to modern molecular design, this note provides a comprehensive overview of the key milestones, influential figures, and pivotal discoveries that have shaped the field of medicinal chemistry. – Synthetic Chemistry: The advent of synthetic organic chemistry revolutionized drug discovery by enabling the synthesis of compounds with precise chemical structures. – Biotechnology and Genomics: The integration of biotechnology and genomics into drug discovery has ushered in the era of personalized medicine. As we continue to unravel the complexities of disease biology and drug action, medicinal chemistry remains at the forefront of transforming scientific discoveries into life-saving treatments for patients worldwide. Previous Previous post: Introduction to Medicinal Chemistry
[3] History and Development of Medicinal Chemistry — History and Development of Medicinal Chemistry Ankur Choudhary 2024-04-17T07:27:06Z Print Online Courses Question Forum No comments Its main purpose is to design, chemically synthesize, and develop new drug formulations by combining synthetic organic chemistry, pharmacology, and other biological specialties.
[4] Medicinal chemistry - Wikipedia — In particular, medicinal chemistry in its most common practice—focusing on small organic molecules—encompasses synthetic organic chemistry and aspects of natural products and computational chemistry in close combination with chemical biology, enzymology and structural biology, together aiming at the discovery and development of new therapeutic agents. At the biological interface, medicinal chemistry combines to form a set of highly interdisciplinary sciences, setting its organic, physical, and computational emphases alongside biological areas such as biochemistry, molecular biology, pharmacognosy and pharmacology, toxicology and veterinary and human medicine; these, with project management, statistics, and pharmaceutical business practices, systematically oversee altering identified chemical agents such that after pharmaceutical formulation, they are safe and efficacious, and therefore suitable for use in treatment of disease.
[6] What is Medicinal Chemistry? | Chemistry | Michigan Tech — Skip to page content Skip to footer navigation Medicinal chemistry is both data-driven science and an art, in which creativity and knowledge is combined to make something new. Medicinal chemists must be able to work effectively with other scientists and researchers to advance the drug discovery process. Adaptability and resilience: Drug discovery is a complex and challenging process that often requires medicinal chemists to adapt to changing circumstances and overcome unexpected obstacles. Each requires different levels of education, from a bachelor's degree to a master's or a PhD in medicinal chemistry. Medicinal chemistry students learn the biochemical processes underlying disease and how drugs interact with biological systems. Medicinal chemistry students study the principles of pharmaceutical formulation and the techniques used to develop and manufacture new drug products.
[8] The optimization of combinatorial drug therapies: Strategies and ... — The goal of drug combination optimization is to achieve target effects with minimal adverse effects, which usually means that the drug synergy is maximized for target effects and minimized for adverse effects, or at a balance between the two (Fig. 1 c,d).
[9] Lower-dose prescribing: Minimizing "side effects" of pharmaceuticals on ... — Personalized adjustment of drug dose also holds the potential for enhancing therapeutic outcomes while simultaneously reducing the incidence of adverse drug events and in lowering patient healthcare costs. Optimizing drug dose is a major factor in improving the sustainability of health care.
[10] How to mathematically optimize drug regimens using optimal control — Next, the goal of the treatment needs to be quantified. Usually we want to maximize the benefits of the therapies and minimize their side effects. When we combine terms representing these effects, using appropriate signs and weights, we obtain a mathematical expression to be optimized.
[12] Advances in drug delivery systems, challenges and future directions — Advances in drug delivery systems, challenges and future directions - PMC Recent drug delivery systems (DDS) are formulated using advanced technology to accelerate systemic drug delivery to the specific target site, maximizing therapeutic efficacy and minimizing off-target accumulation in the body. 104.Ziaie B., Baldi A., Lei M., Gu Y., Siegel R.A. Hard and soft micromachining for BioMEMS: review of techniques and examples of applications in microfluidics and drug delivery. 109.Sutradhar K.B., Sumi C.D. Implantable microchip: the futuristic controlled drug delivery system. 115.Hilt J.Z., Peppas N.A. Microfabricated drug delivery devices. The Application of Carbon Nanotubes in Target Drug Delivery Systems for Cancer Therapies; pp. 138.Zargar S.M., Hafshejani D.K., Eskandarinia A., Rafienia M., Kharazi A.Z. A review of controlled drug delivery systems based on cells and cell membranes.
[15] Drug Interactions (Pharmacokinetics and Pharmacodynamics) — Pharmacokinetic interactions affect the absorption, distribution, metabolism, and excretion of drugs, potentially altering drug levels and therapeutic outcomes. Pharmacodynamic interactions, on the other hand, influence the combined effects of drugs on physiological systems, which can be additive, synergistic, antagonistic, or potentiative.
[19] Principles of pharmacokinetics and pharmacodynamics — Both biopharmaceutics and PK are essential to enhance the results of drug therapies that can support drug product development and the determining of PK-pharmacodynamics models. Further, they also help in the establishment of in vitro-in vivo correlations of the drug. Pharmaceutical scientists need to be thorough with the basics of PK and be
[48] (PDF) TRADITIONAL HERBAL MEDICINES - A REVIEW - ResearchGate — Traditional herbal medicine is the most ancient form of medicine known to man, and plant-based substances account for more than half of all modern clinical drugs (Krishnan, 2018). In the
[50] PDF — the need for a systematic exploration of herbal remedies has gained prominence. The integration of modern scientific approaches provides an opportunity to unravel the mysteries behind the efficacy of traditional herbal formulations, offering insights into the active compounds, mechanisms of action, and potential therapeutic applications.
[56] Computational Drug Design: New Frontiers in Medicine — Computational drug design is revolutionizing medicine by using algorithms and simulations to identify promising drug candidates efficiently. This approach reduces costs and accelerates development compared to traditional experimental methods, making it indispensable in modern pharmaceutical research. Advancements in computational power and molecular modeling have significantly improved
[58] PDF — Ancient origins: Herbal remedies and alchemy The roots of pharmaceuticals can be traced back to ancient civilizations such as Egypt, Mesopotamia, China, and India. These cultures relied on herbal remedies and natural substances to treat various ailments and diseases. Plants like aloe vera, garlic, and opium poppy were among the many botanical sources used for medicinal purposes.
[59] Medicine in the Ancient World - World History Encyclopedia — In this collection, we look at the views on health and medical practice in Mesopotamia, Egpyt, Greece and Rome. We also look at key figures such as the Greek god of medicine Asclepius and famous doctors like Hippocrates whose oath is still sworn today by doctors around the world.
[60] The Evolution of Pharmaceuticals: From Ancient Remedies to Modern — The dawn of the Renaissance brought about a renewed interest in science and exploration, leading to significant advancements in medicine and pharmacology. One of the key figures of this period was Paracelsus, a Swiss physician who rejected the mystical notions of alchemy and emphasized the use of chemical substances in medicine.
[86] PDF — Medicinal chemistry is an interdisciplinary field at the forefront of drug discovery and development, combining the principles of chemistry, biology, pharmacology, and computational sciences to design and synthesize novel therapeutic agents. This abstract provides an overview of the field of medicinal chemistry, highlighting its significance in addressing unmet medical needs, advances in drug
[88] Personalized medicine: the impact on chemistry - PubMed — Personalized medicine: the impact on chemistry - PubMed Search: Search Your saved search Personalized medicine: the impact on chemistry Personalized medicine: the impact on chemistry We examine the intersection of personalized medicine and network pharmacology to identify strategies for the development of personalized therapies that are fully informed by network pharmacology concepts. This provides a framework for discussion of the impact personalized medicine will have on chemistry in terms of drug discovery, formulation and delivery, the adaptations and changes in ideology required and the contribution chemistry is already making. New ways of conceptualizing chemistry's relationship with medicine will lead to new approaches to drug discovery and hold promise of delivering safer and more effective therapies. Santos J, et al.
[91] Personalized Medicine and Advancements in Pharmacology: Shaping the ... — One of the key areas in personalized medicine is genomics, which focuses on analyzing an individual’s genetic information to predict disease susceptibility, determine optimal treatment strategies, and identify potential adverse reactions.1 Pharmacogenomics, a subset of genomics, explores the relationship between an individual’s genetic variations and their response to drugs. By considering individual patient characteristics, including genetic variations, biomarkers, and clinical data, personalized medicine aims to optimize treatment efficacy, minimize adverse effects, and improve patient outcomes across diverse medical fields. Personalized medicine enables tailored treatment approaches based on individual patient characteristics, such as genetic makeup, biomarkers, and clinical data.
[92] Overcoming Challenges in Small-Molecule Drug Bioavailability: A Review ... — Recent advances in medicinal chemistry, drug delivery technologies, and computational modeling have expanded the toolbox available to overcome bioavailability challenges . Strategies range from molecular design modifications and prodrug approaches to innovative formulation techniques like nanocarriers and amorphous solid dispersions [ 14
[93] Editorial: Advances in Drug Formulation - PMC — Many new thoughts and ideas along with their implementation have been enriching formulation development. Among the most recent approaches in the research of drug formulations, idea of nanorobots has emerged as a powerful therapeutic tool to develop highly efficacious precision medicines to localize the drug at the target site ( da Silva Luz et
[94] New Chemical Modalities and Strategic Thinking in Early Drug Discovery ... — New chemical modalities including RNA therapeutics, protein degraders, cyclopeptides, antibody drug conjugates, and gene therapy have matured, demonstrating clinical success and are now considered early in target appraisal. We have seen a slow but steady progress toward these new chemical modalities (e.g., RNA-based approaches, targeted protein degradation, covalent inhibitors, next generation of peptides, antibodies or peptides conjugates, etc.) that have been percolating for several decades and are demonstrating their validity by reaching clinical development and regulatory approval. To evaluate this point, the medicinal chemist needs to consider if the molecule or specific chemical modality can reach the site of action (the compartment where the target is located).
[95] The Role of Cross-disciplinary Collaboration in Drug Discovery — Interdisciplinary collaboration leverages advancements in each field to compensate for the limitations of others. ... such as medicinal chemistry, biology, and pharmacology, work together to refine the properties of the lead compound, such as its potency, selectivity, and safety. ... Examples of successful collaborations.
[96] Fostering Multidisciplinary Collaboration in Drug Discovery — The project teams included specialists from medicinal chemistry, structural biology, preclinical safety, translational medicine and project team leaders, among others (see Table 1). ... Interdisciplinary collaboration in drug discovery requires specialists to be constantly aware of the implications of their domain-specific knowledge creation
[97] The future of biomolecular simulation in the pharmaceutical industry ... — The Protein Data Bank contains over 180 000 biomolecular structures (as of May 2021) determined by X-ray, ... shows the value of this structural information to structure-based drug design. ... for example using antibody-drug conjugates, smart drug-delivery vehicles, theranostics or other biologics, fundamentally new types of computational
[103] PDF — This review provides a comprehensive overview of the key computational methods and tools used in drug discovery, including molecular docking, molecular dynamics simulations, quantum mechanics, and machine learning. Keywords: Computational chemistry, drug discovery, molecular docking, molecular dynamics, quantum mechanics, machine learning, molecular modelling, virtual screening Introduction The pharmaceutical industry has traditionally relied on experimental approaches for drug discovery, a process that is often labor-intensive, time-consuming, and costly. Computational methods in drug discovery Molecular docking is a key computational technique used to predict the preferred orientation of a small molecule (ligand) when bound to a target protein (receptor). Conclusion Computational chemistry has revolutionized modern drug discovery, providing powerful tools and techniques to predict and analyze molecular interactions.
[104] Computer-Aided Drug Design and Drug Discovery - MDPI — In the rapidly evolving landscape of pharmaceutical research, the integration of computational methods has become a cornerstone in drug discovery and development efforts. Computer-aided drug design (CADD) offers a more efficient and cost-effective approach, complementing traditional experimental techniques. By leveraging computational tools such as molecular modeling, structure-activity
[105] PDF — Example 2: Molecular docking facilitated the discovery of novel antifungal agents by 3246 NeuroQuantology| December 2022 | Volume 20 | Issue 20 |Page 3245-3250|doi: 10.48047/NQ.2022.20.20.NQ109321 Trilochan Ram Sahu et al/APPLICATIONS OF COMPUTATIONAL CHEMISTRY IN DRUG DESIGN: A REVIEW eISSN1303-5150 www.neuroquantology.com predicting their binding modes with fungal enzymes (Ferreira et al., 2015). AI and Machine Learning in Drug Design Dynamics Simulations in Protein-Ligand Interactions GROMACS Mechanistic understanding of drug resistance mechanisms Beta-Lactamase AMBER Exploration of ligand binding dynamics and allosteric modulation GPCR Desmond Prediction of binding affinity and selectivity of kinase inhibitors Enzyme Kinase 3248 NeuroQuantology| December 2022 | Volume 20 | Issue 20 |Page 3245-3250|doi: 10.48047/NQ.2022.20.20.NQ109321 Trilochan Ram Sahu et al/APPLICATIONS OF COMPUTATIONAL CHEMISTRY IN DRUG DESIGN: A REVIEW eISSN1303-5150 www.neuroquantology.com AI and machine learning algorithms are revolutionizing drug design by accelerating virtual screening, predicting molecular interactions, and optimizing lead compounds (Schneider et al., 2020).
[126] Special Issue: Exploring the Use of AI/ML Technologies in Medicinal ... — This Special Issue in ACS Medicinal Chemistry Letters highlights cutting-edge AI/ML advancements, including deep generative models, ... optimizing high-throughput medicinal chemistry workflows. Additionally, user-focused machine-learning frameworks are advancing drug discovery for conditions like inflammatory bowel disease (IBD), while open
[127] Real-World Applications and Experiences of AI/ML Deployment for Drug ... — The emergence of artificial intelligence (AI) and machine learning (ML) in the field of drug discovery has been propelled by significant advances in computer science, infrastructure, and the surge of "big data". ... It is noteworthy that the use of ML in medicinal chemistry began more than 40 years ago. However, with recent advances in the
[135] Structure-based drug design | Drug Discovery News — Iterative cycles of design, synthesis, and testing refine the compounds to optimize their pharmacological properties. Structure-based drug design has been instrumental in developing a number of successful drugs and continues to be a powerful strategy for discovering new therapeutic agents. Understanding protein structure
[138] Structure-based Drug Design vs. Ligand-based Drug Design — Not every discovery project has an available 3D structure of the protein target. In this case, researchers could flip the script and look at ligands that are known to bind to the target of interest and then try to learn from this data how to design even better ligands that might become drugs, a process known as ligand-based drug design (LBDD).
[139] Fundamental considerations in drug design - PMC - PubMed Central (PMC) — Rational drug design approaches have been employed to explore and invent novel molecules against diseases or any dysfunction in the human body.5 Two widely used methods in rational drug design, structure-based drug design and ligand-based drug design, are currently in the drug discovery domain to get rid of the typical trial and error approach.6, 7 Rational drug design mainly focuses on target discovery of hits and lead compounds and optimization of drug-like candidates where thorough data on biochemical and structural characteristics of a protein target would be incorporated. Advanced techniques such as pharmacophore modeling and three-dimensional quantitative structure-activity relationship (3D QSAR) are the familiar tools used in LBDD, which could yield predictive QSAR models for lead molecules optimization and possible key interactions between both ligands and drug targets.
[140] Virtual Screening, Molecular Docking and QSAR Studies in Drug Discovery ... — QSAR models contribute to predicting the biological activities of chemical compounds based on their structural features, enhancing the screening process for potential drug candidates .
[141] Machine learning-based QSAR modeling, molecular docking, dynamics ... — After developing the QSAR model and predicting the activity of anticancer hit compounds, the remaining were docked against anti-cancer targets β-tubulin (4O2B) and c-MET (4XYF). Molecular docking study provides information regarding the binding affinity, docking energy, and selectivity of the probable active hit to their target.
[142] Integrating Atom‐Based 3D‐QSAR, Molecular Docking, and Molecular ... — This study explores the optimization of adenosine A 2A receptor antagonists for Parkinson's disease using a combination of 3D-QSAR modeling, molecular docking, binding energy calculations, and molecular dynamics simulations. CHEMBL4289874 emerged as a highly stable and promising lead compound, showing superior binding affinity and dynamic
[143] Pharmacokinetics/pharmacodynamics in drug development: an industrial ... — Clinical research done properly in the early stages of drug development will also set the stage for designing and conducting optimal "confirming" registrational Phase IIB/III studies for promising drug candidates. Pharmacokinetics (PK) and pharmacodynamics (PD) modeling and simulation are crucial components of a mechanistic approach to optimal
[170] (Pdf) Medicinal Chemistry: Scope, Applications, and Significance in ... — Applications of medicinal chemistry are manifold, from developing novel small molecule drugs and biologics to innovative techniques in target identification and lead optimization.
[172] What Is Medicinal Chemistry? A Comprehensive Overview — Designing a drug requires understanding how molecular structures influence biological activity. Structure-based drug design (SBDD) and ligand-based drug design (LBDD) refine molecular interactions. Computational techniques like molecular docking and quantitative structure-activity relationship (QSAR) modeling help predict how structural modifications influence biological activity. Structure-activity relationship (SAR) guides drug optimization by correlating molecular structure with biological activity. Phase I reactions, mediated by cytochrome P450 enzymes, modify drug structures via oxidation, reduction, or hydrolysis, often converting active compounds into more polar metabolites. Sophisticated analytical techniques confirm purity, structural integrity, and functional interactions, facilitating safe and effective drug development. Combined with computational simulations, these tools continue refining drug development, ensuring therapeutic compounds interact with targets as intended.
[173] What is Medicinal Chemistry? | Chemistry | Michigan Tech — Skip to page content Skip to footer navigation Medicinal chemistry is both data-driven science and an art, in which creativity and knowledge is combined to make something new. Medicinal chemists must be able to work effectively with other scientists and researchers to advance the drug discovery process. Adaptability and resilience: Drug discovery is a complex and challenging process that often requires medicinal chemists to adapt to changing circumstances and overcome unexpected obstacles. Each requires different levels of education, from a bachelor's degree to a master's or a PhD in medicinal chemistry. Medicinal chemistry students learn the biochemical processes underlying disease and how drugs interact with biological systems. Medicinal chemistry students study the principles of pharmaceutical formulation and the techniques used to develop and manufacture new drug products.
[174] Click Chemistry: an overview and recent updates in the medicinal ... — Recently, it has been seen that there is a rapid surge in Click Chemistry (CC) research owing to its fast, reliable, and biocompatible nature, making it an ideal tool for drug discovery. CC approach allows facile and sustainable development of complex molecules with minimal off-target products. With the rapid advancement of the CC field, its applications have significantly expanded across
[188] Pharma breakthroughs: 10 novel drug approvals that made headlines in 2023 — Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. In 2023 to date, 51 novel drugs have been approved by the FDA to manage a broad spectrum of medical conditions – from Alzheimer’s disease and cancer to migraines, menopausal symptoms and post-partum depression. Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
[189] Global first-in-class drugs approved in 2023-2024: Breakthroughs and ... — Global first-in-class drugs approved in 2023-2024: Breakthroughs and insights - ScienceDirect First-in-class (FIC) drugs are considered the main drivers of new drug discovery and have novel targets and mechanisms. From a global perspective, 81 FIC drugs were approved in 2023 and 2024. As for innovations regarding mechanism-based therapies, diverse enzymes were the most common FIC drugs (32.1%), with 26 novel targets identified. In this review, the performance and characteristics of FIC drug approvals in 2023 and 2024 will be presented, providing information on breakthroughs and insights for global drug discovery. First-in-class (FIC) drugs with a new target or mechanism hold the key to driving new drug discovery. For all open access content, the Creative Commons licensing terms apply.
[197] Comparative Effectiveness of Dual Biologic Therapy and Biologic Small ... — Patients with refractory inflammatory bowel disease (IBD) face difficulty in the treatment strategy. Combined advanced targeted therapies may obtain higher therapeutic efficacy. However, few studies compare the efficacy and safety of dual biologic therapy (DBT) with biologic small‐molecule therapy (BMT) for refractory IBD.
[198] Advancements in the co-formulation of biologic therapeutics — Therapies have also been developed that use a combination of small molecules and macromolecular biologics for the treatment of complex infectious diseases . An example of a new biologic co-formualtion is HyQvia (immune globulin infusion 10% (human) with recombinant human hyaluronidase), a once-monthly treatment for adult patients with
[200] What are Small Molecule Drugs? - Patheon pharma services — Key characteristics of small molecule drugs: Size and structure: Their small size, usually between 0.1 and 1 kDa, enhances GI absorption into the bloodstream, making them suitable for oral use. Composition: These compounds are often hydrophobic and crystalline, allowing them to bypass lipid-rich cell membranes and exert their therapeutic effects.
[201] Overview of biopharmaceuticals and comparison with small-molecule drug ... — The drug-like properties of a small molecule compound are defined by its physicochemical characteristics (solubility, permeability, and stability), structure, molecular weight, lipophilicity, pK a, polar surface area, shape and reactivity; and by its biochemical attributes such as metabolism, drug-drug interactions, and cellular uptake and
[207] PDF — healthcare. In this narrative, we delve into the key challenges facing synthetic medicinal chemistry and the strategies employed to overcome them . One of the primary challenges in synthetic medicinal chemistry is the optimization of drug-like properties, including potency, selectivity, solubility, and metabolic stability.
[208] PDF — Dahms HU. Challenges in Medicinal Chemistry. J Chem Bio and Med Chem. November-2017;1(1):3. The number of approved drugs for the market is decreasing in recent years and calls for more effective methods to discover a higher number of successful compound candidates. Medicinal chemistry at the forefront is
[209] Challenges for medicinal chemistry - ScienceDirect — REVIEWS Challenges for medicinal chemistry Gtinther Wess Medicinal chemistry has become the most time- consuming step in the drug discovery process, and new discovery technologies are likely to increase the burden on lead optimization and refinement. Although medicinal chemists are able to optimize hits/leads very quickly and successfully with
[211] Medicinal Chemistry: A Key Driver in Achieving the Global Sustainable ... — For medicinal chemistry, it is essential to integrate the knowledge and skills from different disciplines and sit at tables where different scientific languages are spoken. Today, medicinal chemistry should not only face the already complex endeavor of finding a new drug but also face the complex challenges posed by the SDGs.
[214] Green chemistry in medicinal chemistry: A review on sustainable ... — Green chemistry in medicinal chemistry: A review on sustainable approaches to the synthesis of biologically active compounds World Journal of Advanced Research and Reviews ISSN Approved International Journal with High Impact Factor for fast publication of Research and Review articles Green chemistry in medicinal chemistry: A review on sustainable approaches to the synthesis of biologically active compounds Review Article World Journal of Advanced Research and Reviews, 2024, 24(02), 1371–1382 Article DOI:**** 10.30574/wjarr.2024.24.2.3417 The pharmaceutical industry's commitment to sustainability is reshaping drug development, centering on green chemistry principles to minimize environmental impact without compromising drug efficacy. World Journal of Advanced Research and Reviews (WJARR) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license. Copyright © 2025, World Journal of Advanced Research and Reviews
[216] Harnessing the 12 Green Chemistry Principles for Sustainable ... — By advocating for the integration of One Health principles into the R&D pharmaceutical pipeline, this Perspective promotes green chemistry methodologies to foster the development of environmentally friendly antiparasitic drugs for both human and animal health. Serving as a call to action, scientists are urged to integrate One Health concepts and green chemistry principles into routine drug development practices, thereby paving the way for a more sustainable R&D pharmaceutical pipeline for antiparasitic drugs.
[217] Medicinal Chemistry: A Key Driver in Achieving the Global Sustainable ... — This Perspective highlights the role of medicinal chemistry in advancing key Sustainable Development Goals (SDGs) with a focus on environmental, social, and health impacts. It bridges the gap between sustainable practices and the medicinal chemistry community, encouraging the integration of SDGs in current research and innovation. It introduces a novel perspective by applying SDG-specific
[219] New Chemical Modalities and Strategic Thinking in Early Drug Discovery ... — New chemical modalities including RNA therapeutics, protein degraders, cyclopeptides, antibody drug conjugates, and gene therapy have matured, demonstrating clinical success and are now considered early in target appraisal. We have seen a slow but steady progress toward these new chemical modalities (e.g., RNA-based approaches, targeted protein degradation, covalent inhibitors, next generation of peptides, antibodies or peptides conjugates, etc.) that have been percolating for several decades and are demonstrating their validity by reaching clinical development and regulatory approval. To evaluate this point, the medicinal chemist needs to consider if the molecule or specific chemical modality can reach the site of action (the compartment where the target is located).
[220] Real-World Applications and Experiences of AI/ML Deployment for Drug ... — It is noteworthy that the use of ML in medicinal chemistry began more than 40 years ago. However, with recent advances in the field, particularly the rise of deep learning, these methods are now impacting every stage of the drug discovery process, from early target identification, to hit finding and lead optimization. Examples include virtual
[235] Environmental considerations along the life cycle of pharmaceuticals ... — Environmental considerations along the life cycle of pharmaceuticals: Interview study on views regarding environmental challenges, concerns, strategies, and prospects within the pharmaceutical industry - ScienceDirect Environmental considerations along the life cycle of pharmaceuticals: Interview study on views regarding environmental challenges, concerns, strategies, and prospects within the pharmaceutical industry The pharmaceutical industry has a key role in reducing these impacts in early production phases, but currently has limited possibilities to reduce the environmental exposure arising from drug consumption and end-of-life. The representatives of pharmaceutical industry were overall well aware of the multifaceted environmental challenges related to the life cycle of pharmaceuticals and of their role in improving sustainability in production. For all open access content, the relevant licensing terms apply.
[236] GREENER Pharmaceuticals for More Sustainable Healthcare — At the same time, healthcare, including pharmaceuticals, contributes 4.4% of worldwide greenhouse gas emissions.1 In addition, active pharmaceutical ingredients (APIs) themselves can also cause environmental impacts, for example, on aquatic ecosystems and drinking water resources, following patient use and downstream of production sites.2,3 Thus, although medicines are essential for human health, they also impact the environment, which is also vitally important to human health,4 and almost all of the UNSDGs, including “Life under Water” and “Clean Water and Sanitation”.5 Whether and how current drug discovery and development processes can be adapted to include the GREENER concept are being investigated by a number of pharmaceutical companies, in collaboration with academia and authorities, and stimulated by, e.g., the European Commission.13 Developing greener APIs will help ensure sustainable healthcare by helping to protect the environment, which is also vitally important for human health.3−5,11 Dialogue is required to enable drug discovery and development experts to better understand environmental hazard and risk assessment issues.
[248] Rational Approaches to Improving Selectivity in Drug Design — This method of charge optimization can be used to minimize the electrostatic binding free energy and has been applied in drug design to analyze and improve potency. The concept of charge optimization is illustrated in Figure 4A. More recently, the charge optimization methodology has been applied to selectivity design using a formalism that
[250] The Prodrug Approach: A Successful Tool for Improving Drug Solubility — Moreover, in clinical trials, low-solubility drugs can lead to precipitation and crystalluria, raising additional safety concerns. Poorly soluble drugs have recently been discontinued in clinical assays for this reason . For these reasons, the prodrug approach presents a safe and effective strategy by which to improve the solubility of